What is the size of Clinical Trials Market in India | Key Players & Strategic Developments 2025

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA10939

Publication Date: Nov 2025

What is the growth rate of the India Clinical Trials Market?

According to 6Wresearch internal database and industry insights, the India Clinical Trials Market is expected to grow at a CAGR of 8.9% during 2025‑2031.

The main drivers of this growth are the increasing demand for novel therapeutic development, the cost‑efficient trial ecosystem with a diverse patient population, and the adoption of advanced digital trial technologies enhancing trial speed and data quality.

Growth Factors for India Clinical Trials Industry

A large and heterogeneous patient pool supports faster recruitment and broader study reach.
Cost‑efficient clinical operations compared to many other countries attract trial sponsors.
Regulatory enhancements improve the speed and clarity of trial approvals and oversight.
Growing pharmaceutical and biotechnology activity drives higher outsourcing of trials and CRO services.
The shift to decentralised trial designs and digital health tools enhances efficiency and accessibility.

India Clinical Trials Market Trends

The India Clinical Trials Market is experiencing trends such as increasing use of decentralised and hybrid trial models, which enhance patient convenience and data‑collection flexibility. The market also sees growth in trials for oncology, rare diseases and biologics. Additionally, demand for services such as patient‑recruitment support, electronic data capture, and real‑world evidence is rising as sponsors seek to optimise trial timelines and quality.

View Main Report

Schedule Analyst Call

Emerging Developments in the India Clinical Trials Market

The India Clinical Trials Market is witnessing developments including greater integration of artificial intelligence and machine‑learning for site selection, monitoring and safety‑signal detection. Meanwhile, partnerships between Indian contract research organisations and international sponsors are expanding to deliver full‑service trial capabilities domestically. Investment in patient‑centric technologies and post‑trial follow‑up services is also advancing to meet evolving trial needs.